News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
527,047 Results
Type
Article (44712)
Company Profile (121)
Press Release (482214)
Section
Business (145608)
Career Advice (2400)
Deals (28068)
Drug Delivery (118)
Drug Development (68069)
Employer Resources (148)
FDA (15643)
Job Trends (12017)
News (264613)
Policy (29683)
Tag
Academia (2299)
Alliances (36122)
Alzheimer's disease (1370)
Approvals (15589)
Artificial intelligence (199)
Bankruptcy (307)
Best Places to Work (9263)
Breast cancer (219)
Cancer (1665)
Cardiovascular disease (139)
Career advice (2001)
CAR-T (123)
Cell therapy (356)
Clinical research (54872)
Collaboration (588)
Compensation (378)
COVID-19 (2582)
C-suite (160)
Data (1551)
Diabetes (219)
Diagnostics (5221)
Earnings (58139)
Employer resources (135)
Events (76391)
Executive appointments (526)
FDA (16564)
Funding (520)
Gene therapy (264)
GLP-1 (729)
Government (3859)
Healthcare (14992)
Infectious disease (2700)
Inflammatory bowel disease (118)
Interviews (448)
IPO (13985)
Job creations (3156)
Job search strategy (1667)
Layoffs (484)
Legal (6962)
Lung cancer (241)
Manufacturing (233)
Medical device (11216)
Medtech (11219)
Mergers & acquisitions (14441)
Metabolic disorders (606)
Neuroscience (1790)
NextGen: Class of 2025 (5045)
Non-profit (3189)
Northern California (2001)
Obesity (344)
Opinion (208)
Patents (172)
People (42533)
Phase I (16409)
Phase II (23767)
Phase III (19508)
Pipeline (769)
Policy (117)
Postmarket research (2209)
Preclinical (6582)
Radiopharmaceuticals (206)
Rare diseases (337)
Real estate (4277)
Regulatory (20693)
Research institute (2065)
Resumes & cover letters (401)
Southern California (1668)
Startups (2744)
United States (16946)
Vaccines (690)
Weight loss (265)
Date
Today (15)
Last 7 days (795)
Last 30 days (2474)
Last 365 days (30805)
2025 (4879)
2024 (31456)
2023 (35058)
2022 (45209)
2021 (48651)
2020 (45742)
2019 (36508)
2018 (27620)
2017 (27873)
2016 (25867)
2015 (28076)
2014 (21851)
2013 (17859)
2012 (19070)
2011 (19485)
2010 (17574)
Location
Africa (672)
Arizona (153)
Asia (30899)
Australia (5419)
California (4455)
Canada (1302)
China (325)
Colorado (199)
Connecticut (229)
Europe (75085)
Florida (675)
Georgia (150)
Illinois (373)
Indiana (210)
Maryland (715)
Massachusetts (3396)
Michigan (161)
Minnesota (282)
New Jersey (1279)
New York (1247)
North Carolina (779)
Northern California (2001)
Ohio (139)
Pennsylvania (983)
South America (1035)
Southern California (1668)
Texas (629)
Utah (123)
Washington State (431)
527,047 Results for "ambu a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope
Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
December 6, 2023
·
5 min read
BioCapital
Ohio Physician Becomes the First Doctor in the U.S. to Use Ambu’s Single-Use Duodenoscope in 100 Procedures
Ambu Inc., the world leader in single-use endoscopy, announced that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambu’s new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography procedures.
November 4, 2021
·
4 min read
FDA
Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit
Today, Ambu announces the 510(k) regulatory clearance of the Ambu® aScope™ Gastro and Ambu® aBox™ 2 in the United States. aScope Gastro is Ambu’s first sterile single-use gastroscope and includes new advanced imaging and design features in a combined solution with next-generation display and processor technology.
February 4, 2022
·
4 min read
BioCapital
Ambu Expands Access to Over 1 Million Procedures in the ENT Segment
Ambu continues to advance the market for single-use endoscopy by addressing Fibreoptic Endoscopic Evaluation of Swallowing.
April 19, 2022
·
3 min read
BioCapital
Ambu Awarded National Video Laryngoscope Contract with Vizient Inc.
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Video Laryngoscopes with Vizient Inc.
November 29, 2021
·
3 min read
BioCapital
Ambu Awarded National Single-Use Endoscopy Contract with Vizient, Inc.
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Single-Use Visualization Devices with Vizient Inc., the largest healthcare performance improvement company in the U.S.
December 6, 2021
·
3 min read
IPO
‘Valentine’s Day Massacre’: Deerfield Claims Alcon is Blocking Aurion’s IPO
Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.
February 25, 2025
·
2 min read
·
Tristan Manalac
BioCapital
Ambu Awarded for Excellence in Product Design
The winners of the ‘Red Dot Award: Product Design 2021’ have been announced, and Ambu is a double winner with awards for the company’s cystoscope and duodenoscope – both single-use endoscopes.
April 15, 2021
·
4 min read
Podcast
BridgeBio’s ATTR-CM Approval, Cassava’s Alzheimer’s Failure, Trump’s Cabinet Picks, More
BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for Amvuttra in the indication; Cassava’s controversial Alzheimer’s drug flunks Phase III; Amgen’s MariTide fails to impress investors, Donald Trump’s controversial nominations continue.
November 27, 2024
·
1 min read
·
Heather McKenzie
Regulatory
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a previous pause.
January 22, 2025
·
2 min read
·
Tristan Manalac
1 of 52,705
Next
